Graham J, Earnshaw S, Lim J, Luthra R, Borker R. Cost-effectiveness of afatinib versus erlotinib in the first-line treatment of patients with metastatic non-small cell lung cancer with EGFR Exon 19 deletion mutations. JCP. 2016 May;2(4):31-9.
Kosa KM, Cates SC, Ball M, Godwin SL, Coppings RJ. Consumers' response and preparedness to ensure food safety during extended power outages: findings from a national survey. International journal of food safety, nutrition and public health. 2014 Jul 17;5(1):34-45. doi: 10.1504/IJFSNPH.2014.063503
Garcia-Alvarez A, Garcia-Albeniz X, Esteve J, Rovira M, Bosch X. Cardiotoxicity of tyrosine-kinase-targeting drugs. Cardiovasc Hematol Agents Med Chem. 2010 Jan;8(1):11-21.